Harvard Bioscience Q3 Adjusted EPS $0.01 Misses $0.04 Estimate, Sales $25.36M Miss $28.02M Estimate
Portfolio Pulse from Benzinga Newsdesk
Harvard Bioscience (NASDAQ:HBIO) reported Q3 earnings of $0.01 per share, missing the analyst consensus estimate of $0.04 by 75%. The company also reported quarterly sales of $25.36 million, missing the analyst consensus estimate of $28.02 million by 9.48%. This represents a 5.79% decrease over sales of $26.92 million the same period last year.
November 07, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Harvard Bioscience's Q3 earnings and sales missed analyst estimates, which could negatively impact the stock in the short term.
Harvard Bioscience's Q3 earnings and sales fell short of analyst estimates. This underperformance is likely to negatively impact investor sentiment and could lead to a decrease in the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100